Musli Thyropeutics

About

Musli Thyropeutics offers a treatment that induces hypofunction of the thyroid gland in order to slow and inhibit cancer progression and enhance the efficacy of chemotherapy and radiotherapy. Current research is based on induction of hypothyroxinemia adjunct to conventional therapies in glioblastoma multiforme patients. The treatment's safety and efficacy are also being assessed, and the research is supported by the Tel Aviv Sourasky Medical Center.

Facts

Team (3)

News mentions (1)

1. Nov 14, 2016 — clinicaltrials.gov: Article